HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.375
+0.105 (3.21%)
Feb 4, 2025, 4:00 PM EST - Market closed
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2024. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
$980
Profits / Employee
-$508,305
Market Cap
3.31M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 15 | 3 | 25.00% |
Apr 30, 2023 | 12 | 0 | - |
Apr 30, 2022 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
HSCS News
- 7 weeks ago - HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 2 months ago - HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewsWire
- 4 months ago - HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 5 months ago - HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 5 months ago - HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - GlobeNewsWire
- 6 months ago - HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - GlobeNewsWire
- 6 months ago - Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewsWire
- 6 months ago - HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewsWire